<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">A strategy using transgenic mice overexpressing the MERS-CoV receptor hCD26/DPP4 was also needed to replicate the severity of human MERS (
 <xref rid="bb0010" ref-type="bibr">Agrawal et al., 2015</xref>). When hCD26/DPP4 mice were infected with moderate loads of MERS-CoV, significant brain damage occurred, mainly localized in the brainstem, where perivascular cuffing, apoptotic bodies, and activated microglia were observed. Conversely, only a mild meningitis occurred in the cortex (
 <xref rid="bb0735" ref-type="bibr">Tao et al., 2016</xref>).
</p>
